Mechanisms and treatment of neuropathic pain

Central Nervous System Agents in Medicinal Chemistry

Volumn 9, Issue 1, 2009, Pages 71-78

  Vranken, Jan H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; CAPSAICIN; CARBAMAZEPINE; DESIPRAMINE; DULOXETINE; ETIRACETAM; FELBAMATE; GABAPENTIN; IMIPRAMINE; KETAMINE; LAMOTRIGINE; LIDOCAINE; MEXILETINE; MONOAMINE OXIDASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; PREGABALIN; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VIGABATRIN; ZONISAMIDE;

ADRENERGIC SYSTEM; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE MODEL; DRUG ERUPTION; DRUG SAFETY; EPILEPSY; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEART DISEASE; HUMAN; NERVE CELL; NERVE INJURY; NEUROCHEMISTRY; NEUROPATHIC PAIN; NOCICEPTIVE RECEPTOR; NONHUMAN; REVIEW; SENSORY SYSTEM; SEROTONIN SYNDROME; STEVENS JOHNSON SYNDROME; TRIGEMINUS NEURALGIA; URINE RETENTION;

AFFERENT PATHWAYS; ANALGESICS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLINICAL TRIALS AS TOPIC; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; KETAMINE; NERVE FIBERS, MYELINATED; NEURALGIA; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PAIN, INTRACTABLE; PERIPHERAL NERVOUS SYSTEM DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSORY RECEPTOR CELLS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 62549157420     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152409787601932     Document Type: Review

References (85)

1. Jensen, T.S.; Gottrup, H.; Sindrup, S.H.; Bach, F.W. The clinical picture of neuropathic pain. Eur. J. Pharmacol., 2001, 429 (1-3), 1-11.
2. Chong, M.S.; Bajwa, Z.H. Diagnosis and treatment of neuropathic pain. J. Pain Symptom Manage, 2003, 25 (5), S4-S11.
3. Rasmussen, P.V.; Sindrup, S.H.; Jensen, T.S.; Bach, F.W. Symptoms and signs in patients with suspected neuropathic pain. Pain, 2004, 110 (1-2), 461-469.
4. Romanelli, P.; Esposito V. The functional anatomy of neuropathic pain. Neurosurg. Clin. N. Am., 2004, 15 (3), 257-68.
5. Bridges, D.; Thompson, S.W.; Rice, A.S. Mechanisms of neuropathic pain. Br. J. Anaesth., 2001, 87 (1), 12-26.
6. Millan, M.J. The induction of pain: An integrative review. Prog. Neurobiol., 1999, 57 (1), 1-164.
7. Willis, W.D.; Westlund, K.N. Neuroanatomy of the pain system and of the pathways that modulate pain. J. Clin. Neurophysiol., 1997, 14 (1), 2-31.
8. Sommer, C.; Kress, M. Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett., 2004, 361 (1-3), 184-7.
9. Ito, S.; Okuda-Ashitaka, E.; Minami, T. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci. Res., 2001, 41 (4), 299-332.
10. Snider, W.D.; McMahon, T. Tackling pain at the source: New ideas about nociceptors. Neuron, 1998, 20 (4), 629-32.
11. Field, M.J.; Hughes, J.; Singh, L. Further evidence for the role of the 2 -subunit of voltage dependent calcium channels in models of neuropathic pain. Br. J. Pharmacol., 2000, 131 (2), 282-6.
12. Dickenson, A.H.; Matthews, E.A.; Suzuki, R. Neurobiology of pain: mode of action of anticonvulsants. Eur. J. Pain, 2002, 6, A51-60.
13. 2+ channels to treat pain: T- type versus N-type. Trends Pharmacol. Sci., 2004, 25 (9), 465-70.
14. Wood, J.N.; Boorman, J.P.; Okuse, K.; Baker, M.D. Voltage-gated sodium channels and pain pathways. J. Neurobiol., 2004, 61 (1), 55-71.
15. Hains, B.C.; Klein J.P.; Saab, C.Y.; Craner, M.J.; Black, J.A.; Waxman, S.G. Upregulation of sodium channel Nav 1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J. Neurosci., 2003, 23, 8881.
16. Attal, N.; Bouhassira, D. Mechanisms of pain in peripheral neuropathy. Acta Neurol. Scand. Suppl, 1999, 173, 12-24.
17. Bolay, H.; Moskowitz, M.A. Mechanisms of pain modulation in chronic syndromes. Neurology, 2002, 59 (5 Suppl 2), S2-S7.
18. Devor, M.; Wall P.D.; Catalan, N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain, 1992, 48 (2), 261-8.
19. Amir, R.; Devor, M. Ongoing activity in neuroma afferents bearing retrograde sprouts. Brain Res., 1993, 630 (1-2), 283-8.
20. McLachlan, E.M.; Janig, W.; Devor, M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal ganglia. Nature, 1993, 363 (6429), 543-6.
21. Devor, M.;, Jaenig, W.; Michaelis, M. Modulation of activity in dorsal root ganglion neurons by sympathetic activation in nerve-injured rats. J. Neurophysiol., 1994, 71 (1), 38-47.
22. Costignan, M.; Woolf, C.J. Pain: molecular mechanisms. J. Pain, 2000, (Suppl.) 1 (3), 35-44.
23. Baranauskas, G.; Nistri, A. Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog. Neurobiol., 1998, 54 (3), 349-65.
24. Dickenson, A.H.; Chapman, V.; Green, G.M. The pharmacology of excitatory and inhibitory amino-acid-mediated events in the transmission and moduclation of pain in the spinal cord. Gen. Pharmacol., 1997, 28 (5), 633-8.
25. Woolf, C.J. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann. Intern. Med., 2004, 140 (6), 441-51.
26. Woolf, C.J.; Shortland, P.; Coggeshall, R.E. Peripheral nerve injury triggers central sprouting of myelinated fibers. Nature, 1992, 355 (6355), 75-8.
27. Woolf, C.J.; Shortland, P.; Reynolds, M.; Ridings, J.; Doubell, T.; Coggeshall, R.E. Reorganization of central terminals of myelinated primary afferents in the rat dorsal horn following peripheral axotomy. J. Comp. Neurol., 1995, 360 (1), 121-34.
28. Tsuda, M.; Inoue, K.; Salter, M.W. Neuropathic pain and spinal microglia: A big problem from molecules in 'small' glia. Trends Neurosci., 2005, 28 (2), 101-7.
29. Marchand, F.; Perretti, M.; McMahon, S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci., 2005, 6 (7), 521-32.
30. Woolf, C.J.; Mannion, R.J. Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet, 1999, 353 (9168), 1959-64.
31. Draisci, G.; Kaiander, K.C.; Dubner, R.; Bennett, G.J.; Iadarola, M.J. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and in mammation. Brain Res., 1991, 560 (1-2), 186-92.
32. Bhisitkul, R.B.; Kocsis, J.D.; Gordon, T.R.; Waxman, S.G. Trophic influence of the distal nerve segment on GABAA receptor expression in axotomized adult sensory neurons. Exp. Neurol., 1990, 109 (3), 273-8.
33. Woolf, C.J. Dissecting out mechanisms responsible for peripheral neuropathic pain: Implications for diagnosis and therapy. Life Sci., 2004, 74 (21), 2605-10.
34. De Groot, J.F.; Coggeshall, R.E.; Carlton, S.M. Opioid receptor plasticity in the superficial dorsal horn following sciatic nerve transaction. Am. Soc. Neurosci., 1997, 23, 1015.
35. Millan, M.J. Descending control of pain. Prog. Neurobiol., 2002, 66 (6), 355-474.
36. Dworkin, R.H. ; O'Conner, A.B. ; Backonja, M. ; Farrar, J.T.; Finnerup, N.B.; Jensen, T.S.; Kalso, E.A.; Loeser, J.D.; Miask- owski, C.; Nurmikko, T.J.; Portenoy, R.K.; Rice, A.S.; Stacey, B.R.; Treede, R.D.; Turk, D.C.; Wallace M.S. Pharmacological management of neuropathic pain: Evidence-based recommendations. Pain, 2007, 132 (3), 237-51.
37. Rowbotham, M.C.; Twilling, L.; Davies, P.S.; Reisner, L,; Taylor, K.; Mohr, D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N. Engl. J. Med., 2003, 348 (32), 1223-32.
38. Ballantine, J.C.; Mao, J. Opioid therapy for chronic pain. N. Engl. J. Med., 2003, 349 (20), 1943-53.
39. Raja, S.N.; Haythornthwaite, J.A.; Pappagallo, M.; Clark, M.R.; Travison, T.G.; Sabeen, S.; Royall, R.M.; Max, M.B. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology, 2003, 59 (7), 1015-21.
40. McCleane, G. Pharmacological management of neuropathic pain. CNS Drugs, 2003, 17, 1031.
41. Namaka, M.; Gramlich, C.R.; Ruhlen, D.; Melanson, M.; Sutton, I.; Major, J. A treatment algorithm for neuropathic pain. Clin. Ther., 2004, 26 (7), 951-979.
42. Stacey, B.R. Management of peripheral neuropathic pain. Am. J. Phys. Med. Rehabil., 2005, 84 (3), S4-S16.
43. Collins, S.L.; Moore, A.; McQuay, H.J.; Wiffen, P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J. Pain Symptom Manage., 2000, 20 (6), 449-58.
44. Kakuyama, M.; Fukuda K. The role of antidepressants in the treatment of chronic pain. Pain Rev., 2000, 7, 119.
45. Sindrup, S.H.; Otto, M.; Finnerup, N.B.; Jensen T.S. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol., 2005, 96, 399.
46. Soderpalm, B. Anticonvulsants: aspect of their mechanisms of action. Eur. J. Pain, 2002, 6 (Suppl. A), 3-9.
47. Jensen, T.J. Anticonvulsants in neuropathic pain: Rationale and clinical evidence. Eur. J. Pain, 2002, 6 (Suppl. A), 61-8.
48. Spina, E.; Perugi, G. Antiepileptic drugs: Indications other than epilepsy. Epileptic Disord., 2004, 6, 57.
49. Chong, M.S.; Smith, T.E. Anticonvulsants for the management of pain. Pain Rev., 2000, 7, 129.
50. Guay, D.R. Oxcarbazepine, topiramate, levetiracetam, and zonisamide: Potential use in neuropathic pain. Am. J. Geriatr. Pharmacother., 2003, 1 (1), 18-37.
51. Finnerup, N.B.; Sindrup, S.H.; Bach, F.W.; Johannesen, I.L.; Jensen, T.S. Lamotrigine in spinal cord injury: A randomized controlled trial. Pain, 2002, 96 (3), 375-83.
52. Gilron, I.; Bailey, J.M.; Tu, D.; Holden, R.R.; Weaver, D.F.; Houlden, R.L. Morphine, gabapentin, or their combination for neuropathic pain. N. Engl. J. Med., 2005, 352 (13), 1324-1334.
53. Nicholson, B. Gabapentin use in neuropathic pain syndromes. Acta Neurol. Scand., 2000, 101 (6), 359-71.
54. Bennett, M.I.; Simpson, K.H. Gabapentin in the treatment of neuropathic pain. Palliat. Med., 2004, 18 (1), 5-11.
55. Rogawski, M.A.; Loscher, W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat. Med., 2004, 10 (7), 685-92.
56. Frampton, J.E.; Foster, R.H. Pregabalin in the treatment of postherpetic neuralgia. Drugs, 2005, 65 (1), 111-118.
57. Ryvlin, P. Defining success in clinical trials - profiling pregabalin, the newest AED. Eur. J. Neurol., 2005, 12 (Suppl 4), 12-21.
58. Vinik, A. Clinical Review: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J. Clin. Endocrinol. Metab., 2005, 90 (8), 4936-4945.
59. Vranken, J.H.; Dijkgraaf, M.G.; Kruis, M.R.; van der Vegt, M.H.; Hollmann, M. W.; Heesen, M. Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain, 2008, 136 (1-2), 150-7.
60. Galer, B.S.; Jensen, M.P.; Ma, T.; Davies, P.S.; Rowbotham, M.C. The lidocaine patch 5% effectively treats all neuropathic pain qualities: Results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin. J. Pain, 2002, 18 (5), 297-301.
61. Meier, T.; Wasner, G.; Faust, M. Kuntzer, T.; Ochsner, F.; Hueppe, M.; Bogousslavsky, J.; Baron R. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes : A randomized, double-blind, placebo-controlled study. Pain, 2003, 106 (1-2), 151-8.
62. Sindrup, S.H.; Jensen, T.S. Pharmacologic treatment of pain in polyneuropathy. Neurology, 2000, 55 (7), 915-20.
63. Lynch, M.E.; Clark, A.J.; Sawynok, J.; Sullivan, M.J.L. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes. Anesthesiology, 2005, 103 (1), 140-6.
64. Fisher, K.; Coderre, T.J.; Hagen, N.A. Targeting the NMDA receptor for chronic pain management: Preclinical animal studies, recent clinical experience and future research directions. J. Pain Symptom Manage., 2000, 20 (5), 358-7.
65. Weinbroum, A.A.; Ben-Abraham, R. Dextromethorphan and dexmedetomidine: New agents for the control of perioperative. Pain Eur. J. Surg., 2001, 167 (8), 563-9.
66. Sang, C.N.; Booher, S.; Gilron, I.; Parada, S.; Max, M.B. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: Efficacy and dose-response trials. Anesthesiology, 2002, 96 (5), 1053-61.
67. Marchettini, P.; Teloni, L.; Formaglio, F.; Lacerenza, M. Pain in diabetic neuropathy case study: whole patient management. Eur. J. Neurol., 2004, 11 (Suppl 1), 12-21.
68. Sang, C.N. NMDA-Receptor Antagonists in neuropathic pain: Experimental methods to clinical trials. J. Pain Symptom Manage., 2000, 19 (1 Suppl), S21-5.
69. Wiech, K.; Kiefer, R.T.; Topfner, S.; Preissl, H.; Braun, C.; Unertl, K.; Flor, H.; Birbaumer N. A placebo-controlled randomized cross-over trial of the N-Methyl-d-aspartate acid receptor antagonist, memantine in patients with chronic phantom limb pain. Anesth. Analg., 2004, 98 (2), 408-13.
70. Hocking, G.; Cousins, M.J. Ketamine in chronic pain mangement: an evidence-based review. Anesth. Analg., 2003, 97 (6), 1730-9.
71. Vranken, J.H.; Dijkgraaf, M.G.; Kruis, M.R.; van Dasselaar, N.T.; van der Vegt, M.H. Iontophoretic administration of S (+)-ketamine in patients with intractable central pain: A placebo-controlled trial. Pain, 2005, 118 (1-2), 224-31.
72. Fisher, K.; Hagen, N.A. Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: A case report. J. Pain Symptom Manage., 1999, 18 (1), 61-6.
73. Enarson, M.C.; Hayes, H.; Woodruffe, M.A. Clinical experiences with oral ketamine. J. Pain Symptom Manage, 1999, 17 (5), 384-386.
74. Fromm, G.H.; Terrence, C.F.; Chatta, A.S. Baclofen in the treatment of trigeminus neuralgia: Double blind study and long term follow up. Ann. Neurol., 1984, 15 (3), 240-4.
75. Chabal, C.; Jacobson, L.; Mariano, A.; Chaney, E.; Britell, C.W. The use of oral mexiletine for the treatment of peripheral nerve injury. Anesthesiology, 1992, 76 (4), 513-7.
76. Eisenach, J.C.; De Kock, M.; Klimscha, W. Alpha 2 adrenergic agonists for regional anesthesia: A clinical review of clonidine (1984-1995). Anesthesiology, 1996, 85 (3), 655-74.
77. Davis, K.D.; Treede, R.D.; Raja, S.N.; Meyer, R.A.; Campbell, J.N. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain, 1991, 47 (3), 309-17.
78. Giller, C.A. The neurosurgical treatment of pain. Arch. Neurol., 2003, 60 (11), 1537-40.
79. Sanders, M.; Zuurmond, W.W.A. Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients. J. Clin. Oncol., 1995, 13 (6), 1509-12.
80. Yang, E.H.; Barsness, G.W.; Gersh, B.J.; Chandrasekaran, K.; Lerman, A. Current and future treatment strategies for refractory angina. Mayo Clin. Proc., 2004, 79 (10), 1284-92.
81. Cameron, T. Safety and efficacy of spinal cord stimulation for the treatment of pain: A 20-year literature review. J. Neurosurg., 2004, 100 (3 Suppl Spine), 254-67.
82. Browna, J.A.; Barbaro, N.M. Motor cortex stimulation for central and neuropathic pain: Current status. Pain, 2003, 104 (4), 431-5.
83. Finnerup, N.B.; Otto, M.; McQuay, H.J.; Jensen, T.S.; Sindrup, S.H. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain, 2005, 118 (3), 289-305.
84. Raja, S.N.; Haythornthwaite, J.A. Combination therapy for neuropathic pain - Which drugs, which combination, which patients? N. Engl. J. Med., 2005, 352 (13), 1373-1375.
85. Ilse, W.K. Neuropathic pain: mechanisms, diagnosis, and treatment. Can. J. Comp. Med. Educ., 2002, 14, 99.